Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure (Q77746918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

chronic heart failure

1 reference

R K Garg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Gheorghiade

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S M Jafri

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

Progress in Cardiovascular Diseases

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

225-236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

The use of dicumarol as an adjunct to the treatment of congestive heart failure; results in a controlled series of 61 cases

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Idiopathic cardiomyopathy: clinical features, prognosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Activation of coagulation after administration of tumor necrosis factor to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Platelet function, thrombin and fibrinolytic activity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

The coagulation system is activated in idiopathic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effects of warfarin on markers of hypercoagulability in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Endothelin in human congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Chronic heart failure in the United States: a manifestation of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

The natural history of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Ventricular dysfunction and the risk of stroke after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Idiopathic myocardial hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Antithrombotic therapy in cardiac disease: an approach based on pathogenesis and risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Flow characteristics in the dilated left ventricle with thrombus: qualitative and quantitative Doppler analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Dilated cardiomyopathies of the adult (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Intracardiac thrombi and systemic embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

A plea for a clinical trial of anticoagulation in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

PRIMARY MYOCARDIAL DISEASE: REPORT OF FIFTY CASES AND REVIEW OF THE SUBJECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Serial echocardiograms in patients with congestive cardiomyopathies: lack of evidence for thrombus formation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Low incidence of stroke in ambulatory patients with heart failure: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Transesophageal echocardiographic assessment of embolic sources: intracardiac and extracardiac masses and aortic degenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Dicumarol therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Dicumarol prophylaxis of thromboembolic disease in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

A study of the beneficial effects of anticoagulant therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Mode of death in chronic heart failure. A request and proposition for more accurate classification

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Hemorrhagic complications of anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Is aspirin safe for patients with heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Is aspirin safe in heart failure? more data

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

Cardiac thrombus in dilated cardiomyopathy. Relationship between left ventricular pathophysiology and left ventricular thrombus

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2898%2980057-1

7 January 2021

10.1016/S0033-0620(98)80057-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9872608%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference